Ever imagine what the impact of misidentifying the correct mutation could be on cancer or missing critical information in your research? What would the impact of missing an already identified variant be on your research? These questions are best left unanswered by choosing to work with only the best and most comprehensive database for human cancer mutations.
COSMIC is the largest, expert curated manual resource for finding cancer-causing mutations. Founded and maintained by the Wellcome Sanger Institute in 2004, the database attempts to collate all known (published) genetic mutations responsible for human cancers, giving you the best resource for better research and patient outcomes.
Empower your research and diagnosis with the world’s largest database of human cancer mutations
with well over 20,000 users and in excess of 10,000 citations
COSMIC provides genome wide annotation with over 37 million coding mutations plus substantial coverage of all other oncogenic non-coding regions.
Expert curated data, standardized and evaluated for accuracy from peer-reviewed papers by a team of post-doctoral scientists.
Every four months, COSMIC content and features are updated to ensure you remain informed on the latest findings.
COSMIC is constantly being updated with the latest information on cancer mutations. With over 5,000,000 Legacy COSM mutations added in 2019 to 2020, almost double the coding mutations that have been collected over the past 15 years.
COSMIC has been fueling cancer research for the past 15 years. From its humble beginnings, see how this knowledge base plays its part in the fight against cancer and making a difference in patient care.
On March 25, please join us for a LIVE webinar where Dr. Simon Forbes, Head of COSMIC from Wellcome Sanger Institute, (Cambridge, UK) will introduce COSMIC and its hand-curated content, review its functionalities in detail as well as upcoming features.
Clinical decision support software integrated with professional variant interpretation services that enables rapid, evidence-based reporting for NGS oncology testing at scale.
Reimagine your clinical interpretation with same day, expert variant classification services tailored to your oncology panel
Leverage the benefits of automation and expert support to improve test turnaround times and clinical reporting capabilities